Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SCHW
Charles Schwab
SCHW
|
+$1.44B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$1.15B |
| 3 |
GE HealthCare
GEHC
|
+$552M |
| 4 |
Danaher
DHR
|
+$447M |
| 5 |
Strategy Inc
MSTR
|
+$416M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$989M |
| 2 |
Boeing
BA
|
+$893M |
| 3 |
Bank of America
BAC
|
+$753M |
| 4 |
Arthur J. Gallagher & Co
AJG
|
+$750M |
| 5 |
Coca-Cola
KO
|
+$638M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.24% |
| 2 | Technology | 2.87% |
| 3 | Financials | 2.43% |
| 4 | Consumer Discretionary | 2.22% |
| 5 | Industrials | 1.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
14001
CALL
Cytek Biosciences
CTKB
$610M
| $2.41K | ﹤0.01% |
600
-400
| -40% | -$2.07K |
|
14002
PUT
TherapeuticsMD
TXMD
$24M
| $2.4K | ﹤0.01% |
2,600
+2,200
| +550% | +$2.19K |
|
|
YSG
14003
PUT
Yatsen Holding
YSG
$319M
| $2.4K | ﹤0.01% |
500
-2,300
| -82% | -$9K |
|
14004
CALL
OmniAb
OABI
$491M
| $2.4K | ﹤0.01% |
1,000
-9,100
| -90% | -$29.8K |
|
14005
PUT
Seer Inc
SEER
$115M
| $2.37K | ﹤0.01% |
1,400
+200
| +17% | +$435 |
|
14006
PUT
Mind CTI
MNDO
$20.6M
| $2.34K | ﹤0.01% |
1,300
+700
| +117% | +$1.41K |
|
14007
PUT
WidePoint Corp
WYY
$93.4M
| $2.33K | ﹤0.01% |
700
-39,500
| -98% | -$150K |
|
|
TOUR
14008
CALL
Tuniu
TOUR
$53.2M
| $2.31K | ﹤0.01% |
210
-20
| -9% | -$206 |
|
14009
PUT
Stereotaxis
STXS
$137M
| $2.29K | ﹤0.01% |
1,300
-2,800
| -68% | -$5.96K |
|
14010
CALL
Banco Santander Chile
BSAC
$16.3B
| $2.28K | ﹤0.01% |
100
-200
| -67% | -$4.27K |
|
|
HYAC.WS
14011
DELISTED
Haymaker Acquisition Corp 4 Warrants
HYAC.WS
| $2.26K | ﹤0.01% |
10,801
-15,607
| -59% | -$2.92K |
|
14012
CALL
US Global Investors
GROW
$39.4M
| $2.26K | ﹤0.01% |
1,000
-8,700
| -90% | -$20.8K |
|
14013
PUT
InflaRx
IFRX
$300M
| $2.24K | ﹤0.01% |
2,200
+100
| +5% | +$189 |
|
14014
PUT
HBT Financial
HBT
$1.35B
| $2.24K | ﹤0.01% |
100
-300
| -75% | -$7.06K |
|
|
INCR
14015
CALL
Intercure
INCR
$58.6M
| $2.24K | ﹤0.01% |
1,600
-6,500
| -80% | -$10.5K |
|
14016
CALL
CNB Financial Corp
CCNE
$1.03B
| $2.23K | ﹤0.01% |
+100
| New | +$2.43K |
|
14017
CALL
RAVE Restaurant Group
RAVE
$43.2M
| $2.2K | ﹤0.01% |
800
-5,800
| -88% | -$15.5K |
|
|
CMCT
14018
PUT
Creative Media & Community Trust
CMCT
$14M
| $2.19K | ﹤0.01% |
3
+2
| +200% | +$3.62K |
|
14019
CALL
Viemed Healthcare
VMD
$350M
| $2.18K | ﹤0.01% |
300
-1,900
| -86% | -$14.9K |
|
14020
CALL
Aveanna Healthcare
AVAH
$2.68B
| $2.17K | ﹤0.01% |
400
-3,500
| -90% | -$16.5K |
|
14021
Virtus InfraCap US Preferred Stock ETF
PFFA
$2.53B
| $2.16K | ﹤0.01% |
102
-95,529
| -100% | -$2.1M |
|
14022
PUT
loanDepot
LDI
$303M
| $2.14K | ﹤0.01% |
1,800
-8,400
| -82% | -$13.6K |
|
|
ATXS
14023
CALL
DELISTED
Astria Therapeutics
ATXS
| $2.14K | ﹤0.01% |
400
+300
| +300% | +$2.1K |
|
14024
Iveda Solutions Warrant
IVDAW
$77.7K
| $2.12K | ﹤0.01% |
12,490
-10,122
| -45% | -$1.81K |
|
14025
PUT
KVH Industries
KVHI
$145M
| $2.12K | ﹤0.01% |
+400
| New | +$2.28K |
|
Similar funds
Ken Griffin's Q1 2025 Portfolio in Review
As of Q1 2025, Ken Griffin held 16,069 positions worth $527B, down 8.7% from $578B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Ken Griffin's Q1 2025 filing shows 1,671 new, 6,327 increased, 6,228 reduced and 1,709 closed positions. Its largest new stake was CMS Energy: 1,417,315 shares worth $106M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $989M.
By sector, the portfolio is most concentrated in Healthcare at 3.2% of assets, up from 3.1% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q1 2025 buy was CMS Energy: 1,417,315 shares worth $106M.
- Ken Griffin added most to Charles Schwab in Q1 2025, an estimated $1.44B increase.
- Ken Griffin's biggest Q1 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $989M.
- Ken Griffin fully exited Walmart Inc in Q1 2025, selling an estimated $462M.
- Ken Griffin's ten largest holdings make up 32% of its $527B portfolio in Q1 2025.
- Ken Griffin opened 1,671 new positions and closed 1,709 in Q1 2025.
- Ken Griffin's portfolio value fell 8.7% quarter-over-quarter to $527B.
Based on Citadel Advisors's 13F filing for Q1 2025, filed 15 May 2025.